Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
|
|
|
- Noel Berry
- 5 years ago
- Views:
Transcription
1 nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D JULPHAR U.A.E GULF PHARMACEUTI CAL INDUSTRIES France Aventis Deutschland UNITED ARAB EMIRATES Germany 06-AA AA0-001 Eli Lilly Export S.A. Eli Lilly and 06-AA0-001 Novo Nordisk A/S Novo Nordisk A/S 06-AA0-001 Mousel Scientific (MSPharma) Iraqi Biocon Limited Indian 06-AA0-001 JULPHAR U.A.E GULF PHARMACEUTI CAL INDUSTRIES France Aventis Deutschland UNITED ARAB EMIRATES Germany 06-AA AA0-002 Eli Lilly Export S.A. Eli Lilly and 06-AA0-002 Novo Nordisk A/S Novo Nordisk A/S 06-AA0-002 Mousel Scientific (MSPharma) Iraqi Biocon Limited Indian 06-AA0-002 JULPHAR U.A.E GULF PHARMACEUTI CAL INDUSTRIES UNITED ARAB EMIRATES 06-AA0-003 Page 1
2 Generic name Units per pack Units per blister"price per pack Lamotrigine 100mg Tablet 30 Tablets / Pack 10 s / blister 3.36 Rifampicin 150mg + Isoniazid 10 PC X 6 PC mg + Ethambutol Hcl 275 mg+ pyrazinamide 400 mg -4 حصر تداولھ في Spiramycin IU units/ml injection 10 ml vial- 1 VIAL OF 10ML units/ml injection units/ml injection 10 ml vial- 1 Vial / Pack units/ml injection Pack of 1 vial units/ml injection 10 ml vial- 10 ml vial / pack Not applicable 3.5 Insulin neutral(human) 100 units 1 VIAL OF 10ML - 2 /ml injection (10 ml vial) (soluble insulin or neutral insulin من الممكن اعطاءه Human Insulin 1000IU/10ML Insulin neutral(human) 100 units /ml injection (10 ml vial) (soluble insulin or neutral insulin من الممكن اعطاءه Insulin neutral 100 units /ml injection 1 Vial / Pack Pack of 1 vial 2.5 Insulin neutral(human) 100 units /ml injection (10 ml vial) (soluble insulin or neutral insulin من الممكن اعطاءه Insulin soluble 30%+70% isophane insulin (biphasic) inj 100 units /ml (limited amount) (10ml vial) انظر 10 ml vial / pack Not applicable VIAL OF 10ML - 2 Page 2
3 Price per unit FOC % No No Page 3
4 nam origmanufacturer nammanufacturer National code France Aventis Deutschland Germany 06-AA0-003 Eli Lilly Export S.A. Eli Lilly and 06-AA0-003 Novo Nordisk A/S Novo Nordisk A/S 06-AA0-003 Mousel Iraqi Biocon Limited Indian 06-AA0-003 Scientific (MSPharma) Pfizer Pfizer Manufacturing belgium NV.,Puurs,belgi Belgium 06-C Merck Export Germany Merck serono SA Switzrland 06-C LG Korea LGLS Korea 06-C Novo Nordisk Health Care A/G Novo Nordisk A/S Pfizer Bulk site: Vetter pharma,fertigun g GmbH & Co.KG, Pfizer Bulk site: Vetter pharma,fertigun g GmbH & Co.KG, SPECIFAR S.A. Pharmaceuti cals GREECE SPECIFAR S.A. Pharmaceuticals JULPHAR U.A.E GULF PHARMACEUTI CAL INDUSTRIES France Bulk site:germany package and Bulk site:germany package and GREECE UNITED ARAB EMIRATES France 06-C C C E E E NDI Iraqi NDI Iraqi 08-E Page 4
5 Generic name Units per pack Units per blister"price per pack Human Insulin 1000IU (35.71MG) Insulin soluble 30%+70% isophane insulin (biphasic) inj 100 units /ml (limited amount) (10ml vial) انظر Insulin soluble 30%+70% isophane insulin (biphasic) inj 100 units /ml Insulin soluble 30%+70% isophane insulin (biphasic) inj 100 units /ml (limited amount) (10ml vial) انظر Human growth hermone (Recombinant)(or somatropin recombinant) injection 4 IU/vial (1mg H.G.H = 3 unit) Human Growth Hormone (Recombinant) (or Somatropin recombinant injection 4IU/vial (1mg H.G.H = 3 unit)) Human Growth hormone (Recombinant ) (or somatropin recombinant) 4IU/ Vial (somatotropin)liquid Growth hormone 15mg/1.5ml -Multi dose prefilled disposable pen ( s.c use) + disposable needle ((1mg H.G.H Somatropin (rbe)powder s.c inj(multi-dose device)5.3 mg (16 IU) cartidage-pen. Somatropin (rbe)powder s.c inj(multi-dose device)12 mg (36 IU)cartidage-pen. 1 Vial / Pack Pack of 1 vial ml vial / pack Not applicable vial + 1 ampoule N/A 9.5 ONE UNIT PER PACK N/A Pre-filled Pen 60 1 unit N/A 35 1 unit N/A Bt x 28tabs 14 Tabs per Blister ( ( 28 TABLETS 7 TABLETS Tablets 10 Tablets 20 ( Page 5
6 Price per unit 2.5 FOC 4.82No No FOC 11.85NA No FOC No FOC % % % Page 6
7 nam origmanufacturer nammanufacturer National code Pioneer IRAQ Pioneer IRAQ 08-E for Pharmaceuti cal Industry for Pharmaceutical Industry EIPICO EGYPT EIPICO EGYPT 08-E Sandoz GmbH Acino Pharma AG Austria SWITZERLA ND for Sandoz GmbH by Lek Pharmaceutical d.d. Slovenia Acino Pharma AG Slovenia/indi a SWITZERLA ND 08-E E MDI Iraq Modern company / industries / Iraq Iraq 08-E Pfizer Wyeth farma SA Spain 08-H Bayer Healthcare LLC Bayer Heathcare LLC 08-H CSL Behring GmbH Germany CSL Behring GmbH Germany 08-H Pfizer Bulk site : Pfizer ireland pharmaceutical, Grange castle- NOVARTIS PHARMA SWITZERLA ND Novartis Pharma AG Bulk site:ireland package a 10-AC EA0-001 Page 7
8 Generic name Units per pack Units per blister"price per pack ( Clopidogrel 75mg as hydrogen sulphate Tablet (Dose :- 75mg Clopidogrl as a Clopidogrel 75mg as Besilate Tablet 14 PC X 2 PC (Dose :- 75mg Clopidogrl as a Clopidogrel 75mg as Besilate Tablet 100 sheet in pack (S 10 tab for one blist (Dose :- 75mg Clopidogrl as a Recombinant factor VIII, 500 IU injection (HAS free ) one single-use vial N/A 192 Recombinant Factor VIII, 500 IU, Injection 1 not applicable vial N/A 845 Etanercept 50 mg pfs 4 Units N/A 1040 Ranibizumab 10 mg / ml (3mg/0.3ml )- ml for intravitreal vial احتیاج ضمني مع 11-EA0-002 code Page 8
9 Price per unit FOC % free goods % % extra goods plus 20 % FOC(Equal to 24,436 packs) N/A 260plus 10 % FOC (Equal to 2,365 packs) 021% Page 9
med Origin of the product Generic name Lenalidomi de 10mg tablet or cap
Company name Company origin Manufacturer name Manufacturer origin National code Generic name Origin of the product Units per pack Units per blister"if applicable " Price per pack Price per unit Type of
ONLINE SUPPLEMENTARY APPENDIX. Webtable 1: Survey facilities random sampling
ONLINE SUPPLEMENTARY APPENDIX Webtable 1: Survey facilities random sampling Delhi, also known as the National Capital Territory (NCT) of Delhi, is divided into total 11 districts namely New Delhi, North
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
List of changes in Out-Patients Formulary
List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
Country of Supplyin g Compan y. Supplyin g Compan y. Novartis Pharma Services Inc. Switzerla nd. Novartis Pharma Services Inc.
Generic Supplin Countr Supplin urin Oriin in c 1/2015 15-B00-029 Imatinib as meslate (Protein Trosine kinase inhibitor) 100m Capsule Glivec 100 Novartis Services Inc. Novartis AG 120 115% 2174.3 $ 1/2015
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
An Overview on Iran Medicine Market and Business Activities of Tamin Pharmaceutical Investment Company (TPICO)
An Overview on Iran Medicine Market and Business Activities of Tamin Pharmaceutical Investment Company (TPICO) TPICO - Office of Strategic Studies Last Updated: Feb 2015 Iran, Islamic Republic at a Glance
List of nationally authorised medicinal products
11 February 2016 EMA/255959/2016 Procedure Management and Committees Support Active substance: calcitonin salmon, synthetic analogue of eel calcitonin Procedure No.: PSUSA/00000494/201506 30 Churchill
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.
1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health
PRAC recommendations on signals
18 May 2017 EMA/PRAC/252869/2017 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the 2-5 May 2017 PRAC meeting This document provides an overview of the recommendations adopted by the Pharmacovigilance
STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, Pack Size. Vial.
1 STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th JANUARY, 2001 Agenda Item No. Company Name/ Formulation Name/Composition Pack Size Existing Price RP
Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage
Injection Techniques Questionnaire (ITQ) WorldWide Results 2014-2015 Insulin Usage BACKGROUND Lipohypertrophy in Diabetes or How much does a lipo cost? Dr. Treichel, Magdeburg Studies * have shown that
List of nationally authorised medicinal products
3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
Member State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Member State Marketing autorisation Holder
Thorazine 25 Mg Iv chlorpromazine hcl 50 mg chlorpromazine 10 mg chlorpromazine tablets uses chlorpromazine tablets ip 100mg thorazine ivpb
Thorazine 25 Mg Iv 1 thorazine cost 2 chlorpromazine thorazine for hiccups 3 chlorpromazine injection dosage 4 recreational thorazine uses 5 chlorpromazine 25 mg/2ml 6 chlorpromazine hcl 50 mg 7 buy chlorpromazine
Pancreatic Cancer Market Research Report- Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1638 Pancreatic Cancer Market Research Report- Global Forecast till 2023 Report / Search Code: MRFR/HC/1107-HCRR Publish
Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
China Insulin Industry Report, Jan. 2011
China Insulin Industry Report, 2010 Jan. 2011 This report analyzes the status, competition pattern and development direction of the insulin industry Focuses on the operation and development prospect of
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on WOMEN S HEALTH, REPRODUCTION AND FERTILITY April 08-09, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions
List of nationally authorised medicinal products
5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
This program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.
OBJECTIVE The intent of the GLP-1 (glucagon-like peptide-1) Agonists [Adlyxin (lixisenatide), Byetta (exenatide), Bydureon (exenatide extended-release), Tanzeum (albiglutide), Trulicity (dulaglutide),
Research and Forecast on China Insulin Market, (Sample)
Research and Forecast on China Insulin Market, 2014-2018 (Sample) Huidian Research Publication Date: April 2014 3. Trend of China Insulin Market in 2013 3.1 Current Situation 3.1.2 Market Scale A survey
Industry Relationships and Institutional Affiliations
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated daily statin: results from the ODYSSEY COMBO II study Christopher
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
SUNY Binghamton, B.S. Biochemistry, 5/80 SUNY Downstate Medical Center, M.D., 6/84
CURRICULUM VITAE RUSSELL D'AMBRA, M.D. July 2014 North Shore Diabetes & Endocrine Associates 3003 New Hyde Park Road Suite 201 New Hyde Park, New York 11042 516-327-0850 EDUCATION: POST-GRADUATE TRAINING:
THYROID HORMONE THERAPY TABLE 21 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR FIGURE 4 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ANALYST S CREDENTIALS...
DBA Design Effectiveness Awards SoloSTAR. A disposable pen injector for insulin
DBA Design Effectiveness Awards 2009 SoloSTAR A disposable pen injector for insulin Category: Sub category: Client company: Design consultancy: Product Consumer Sanofi Aventis GmbH DCA Design International
Country of Supplying Company. Supplying Company. Anfarm Hellas S.A. Greece
01-AA0-006 01-B00-016 Digoxin 250 mcg/ml inj (2ml) Ampoule Spironolactone 25mg Digoxin/Anfar m Spironoam 25 tab Greece Greece 6 8322 4.5 $ Iraq 10 89122 500 ID سامراء Iraq سامراء 02-B00-008 Hyocine butylbromide
Mifegymiso. New Exception Status Benefits
OCTOBER 2017 Nova Scotia Formulary Updates Mifegymiso New Exception Status Benefits Prozac (fluoxetine syr) Neupro (rotigotine) Brenzys (etanercept) Changes in Benefit Status Criteria Updates OAB Medications
SPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES World congress on Polycystic ovarian Syndrome and Fertility October 18-19, 2018 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions PCOS2018
Comparison of the Dose Accuracy of Prefilled Insulin Pens
Journal of Diabetes Science and Technology Volume 3, Issue 1, January 2009 Diabetes Technology Society ORIGINAL ARTICLES Comparison of the Dose Accuracy of Prefilled Insulin Pens Alexander, M.Sc., Johannes
Organ Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Global Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
Advance Notification of Amendments to the April 2015 Drug Tariff
Advance Notification of Amendments to the April 2015 Drug Tariff ADDITIONS Part I - Drugs And Preparations Drug Qty Price Chlorambucil 2mg tablets 25 40.51 A Melphalan 2mg tablets 25 42.88 A Part III Appliances
Package leaflet: Information for the user. Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin
Package leaflet: Information for the user Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin Read all of this leaflet carefully before you start using this medicine because
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge
Injection Techniques Questionnaire (ITQ) WorldWide Results 2014-2015 Needle Gauge BACKGROUND All needles are at least twice as long as the skin is thick More than twice as long 31G =.26mm Surface = 1
SickKids Research Institute: List of Funders
SickKids Research Institute: List of Funders 2009-2010 Agency Funding $ Agency Funding $ 3M Pharmaceuticals 2,901 International Council on Amino Acid Science 80,800 Abbott Diagnostics 6,639 International
TRAVEL. well as these emergencies, so it s a good idea to check your policy with your insurer before you go.
Having diabetes shouldn t affect you when you travel if you plan ahead. Speak to your diabetes team at least 2 weeks before you go away. Also check you have appropriate insurance. Some travel insurance
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children December 2008 This technology summary is based on information available at the time of research and a limited literature
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
Modelling diabetes Professor Alastair Gray Health Economics Research Centre University of Oxford
Oxford Technology Showcase 2016 Big Healthcare Challenges in chronic disease Modelling diabetes Professor Alastair Gray Health Economics Research Centre University of Oxford Chronic diseases.. are long-term
NIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
Price Changes advised by Pharmac As at 12 June 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct
Dose Accuracy of the ClikSTAR, NovoPen 4, and Luxura Insulin Pens: Results of Laboratory and Field Studies
Journal of Diabetes Science and Technology Volume 5, Issue 5, September 2011 Diabetes Technology Society ORIGINAL ARTICLE Arnd, Ph.D., 1 Nils Basso, Ph.D., 2 and Steffen Adler, Ph.D. 1 Abstract Background:
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Tamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS
Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
Diabetes and Endocrinology
CONFERENCES SPONSORSHIP OPPORTUNITIES 2 nd Global Meeting on Diabetes and Endocrinology May 16-17, 2019 Abu Dhabi, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims to
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003
EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)
New Exception Status Benefits
AUGUST 2017 Nova Scotia Formulary Updates New Exception Status Benefits Forxiga (dapagliflozin) Xigduo (dapagliflozin and metformin hydrochloride) Criteria Update: Antipsychotic Medications Abilify (aripiprazole)
Free Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS HLC029D January 2013 Paul Evers Project Analyst ISBN: 0-89336-238-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
Insulin Pens - Medical Devices Pipeline Assessment, 2016
Insulin Pens - Medical Devices Pipeline Assessment, 2016 Insulin Pens - Medical Devices Pipeline Assessment, 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)
Secukinumab in Psoriasis Patients with Concurrent Psoriatic Arthritis: Patient-Reported Outcomes in the Corrona Psoriasis Registry AB Gottlieb, B Strober, 2 AW Armstrong, 3 JD Greenberg, 4,5 C Karki, 4
Approval of Multiple Diabetes Management Products and Mesalazine proposals
8 June Approval of Multiple Diabetes Management Products and Mesalazine proposals PHARMAC is pleased to announce the approval of five agreements in relation to funding of blood glucose, blood glucose diagnostic
Lessons learned from working with international injection technique guidelines
Lessons learned from working with international injection technique guidelines Anders Frid, MD, PhD Clinic of Endocrinology, Skåne University Hospital, Malmö Oslo 23rd March 2012 INJECTION TECHNIQUE IS
TECHNICAL REPORT TR-105. Retention of structural/potency characteristics of Insulins. REFERENCE: ANALYTICAL INVESTIGATIONAL PROTOCOL #EquA 003
TECHNICAL REPORT TECHNICAL REPORT TR-105 Retention of structural/potency characteristics of Insulins REFERENCE: ANALYTICAL INVESTIGATIONAL PROTOCOL #EquA 003 Authored by: Mark Sarno,Vision Biotechnology
Guide for Storage of Insulin
Guide for Storage of Insulin Every effort is made to assure the accuracy of the attached information. This information is not intended to be used as a tool to prescribe medication or provide other clinical
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014
30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
Release of the 2017/18 Invitation to Tender
2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s
HUMULIN 70/30 KwikPen
1 Instructions for Use HUMULIN 70/30 KwikPen (70% human insulin isophane suspension 30% human insulin injection [rdna origin]) 100 units/ml, 3 ml pen Read the Instructions for Use before you start taking
INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.
INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra
Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB
Once-daily oral direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation Kenneth W. Mahaffey, MD and Keith AA Fox, MB ChB on behalf
Pharmaceuticals Import Summary Report. selected countries in MENA region
Pharmaceuticals Import Summary Report selected countries in MENA region Contents.. 3. 3. 3. 3.3....3 5. 5. 5. 6. 6. 6. Disclaimer Global Imports. Imports in MENA Focus Pharmaceutical Categries Vaccines
Smokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
Copenhagen, Denmark September 2014
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients 1 Priorities for Product Development
Types of insulin. Your blood glucose levels. Types of insulin
Different types of insulin are available for people with diabetes. If you need insulin, you and your diabetes team will look at the options and decide which type fits best with your lifestyle and blood
about us Cyndea Pharma independent
2014 02 about us Cyndea Pharma is an independent Spanish laboratory specialized in the development and manufacturing of generic formulations all of which is done in the latest state-of-the-art high containment
Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml
: I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC
MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne
MEDICINES SHORTAGES John Chave - Secretary general Members: Professional Bodies & Pharmacists Associations 2013: 32 Countries Austria Belgium Bulgaria Bosnia Herzegovina Cyprus Czech Rep Denmark Estonia
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION
Saskatchewan Health Drug Plan and Extended Benefits Branch January 2005 Bulletin #101 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION NEW FULL FORMULARY LISTING: The
NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.
S C I Total 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 223.33 6 6 26.7996 250.1296 2 120016 Amitriptyle Tab. IP - 25 mg 10X10 4,120 Micron Pharmaceuticals 27.9 12 3.348 31.248 3 120030
Revised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme 2015 C e n t r a l T B D i v i s i o n D i r e c t o r a t e G e n e r a l o f H e a l t h S e r v i c e s M i n i s t r y o f H e a l t h & F a m i l y
Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate
Package leaflet: Information for the patient Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate Read all of this leaflet carefully before you are given this medicine because
For patients uncontrolled on multiple daily injections of insulin. A quick-start guide for your practice ALL-DAY CONTROL WITH
For patients uncontrolled on multiple daily injections of insulin A quick-start guide for your practice Dosing guidance 1,* V-Go: 3 options 1 For initiating V-Go in patients switching from MDI The majority
Award of Contracts without Competition December 2013
SERIVCES 2850 Open Text Opentext Web CMS Software Support 125,000.00 Business Services Organisation 2259 Lynas Cooked Pork (Lynas) 63,063.00 2703 Limavady Office Products 169,477.00 2817 Merck no 3 Nutritional
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars
PBS Growth The changing composition of the PBS PBS Top 10 drugs in transition Shifting sands for industry as generic volume soars The under co-payment market PBS Update 2014-15 Growth in PBS spending was
PACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Sandoz 500 mg, effervescent tablets Calcium Sandoz 1000 mg, effervescent tablets Calcium Read all of this leaflet carefully because it contains important
POST SHOW REPORT. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets.
The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets. 22 Editions of Success to Reach Excellence. Organised by Strategic Partner POST SHOW REPORT 2018 Supported by
Global EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.
Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference. Product Number API Test product Dose/ mg Manufacturer Country of manufacture Country
Package leaflet: Information for the user
Sandoz B.V. Page 1/8 Package leaflet: Information for the user Pioglitazon Lek 15 mg, tabletten Pioglitazon Lek 30 mg, tabletten Pioglitazon Lek 45 mg, tabletten Pioglitazone Read all of this leaflet carefully
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels Bertrand Cariou, 1 Maja Bujas-Bobanovic, 2 Michael J Louie,